Bristol Myers Squibb (BMY)SVP and Controller sold ~$39K
Phil M Holzer, SVP and Controller at Bristol Myers Squibb, sold ~$39K of Bristol Myers Squibb shares.
- ~$39K
- Approx. value · 700 sh @ $55.62
- 12K
- Holds after · shares reported
- Traded
- Nov 4, 2024
- Filed
- Nov 5, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 3, 2024FDAFDA drug approval: Opdivo
- Nov 1, 2024InsiderOfficer purchased ~$100K of BMY shares in the open market
- Nov 4, 2024 · this disclosureInsiderOfficer sold ~$39K of BMY shares in the open market
What came next
- Dec 6, 2024CongressDisclosed purchase of BMY — reported range $1,001 - $15,000
- Dec 27, 2024FDAFDA drug approval: Opdivo Qvantig
- Dec 27, 2024FDAFDA drug approval: Opdivo Qvantig
- Jan 15, 2025CongressDisclosed purchase of BMY — reported range $1,001 - $15,000
- Jan 28, 2025FDAFDA drug approval: Yervoy
- Feb 14, 2025InsiderOfficer purchased ~$100K of BMY shares in the open market
- Feb 20, 2025InsiderCEO purchased ~$110K of BMY shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Bristol Myers Squibb
For Bristol Myers Squibb, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 45 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BMY page.
Other recent filings by Phil M Holzer, SVP and Controller
The full history of Phil M Holzer, SVP and Controller is on the profile page.
How this filing works
Other disclosures at Bristol Myers Squibb
- SEC Form 4Sep 10, 2026
- SEC Form 144Sep 9, 2026
- SEC Form 4Aug 26, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its BMY page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
